Cardiovascular health in pediatric patients with X-linked hypophosphatemia under two years of burosumab therapy

Overview of attention for article published in Frontiers in endocrinology, May 2024

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 3,491 followers.

RT @MichalLaurent11: Cardiovascular Health in Pediatric Patients with X-Linked Hypophosphatemia (XLH) under Two Years of Burosumab Therapy…

RT @MichalLaurent11: Cardiovascular Health in Pediatric Patients with X-Linked Hypophosphatemia (XLH) under Two Years of Burosumab Therapy…

RT @MichalLaurent11: Cardiovascular Health in Pediatric Patients with X-Linked Hypophosphatemia (XLH) under Two Years of Burosumab Therapy…

RT @MichalLaurent11: Cardiovascular Health in Pediatric Patients with X-Linked Hypophosphatemia (XLH) under Two Years of Burosumab Therapy…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.